Kuschak TI - Search Results

1

A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bisdioxopiperazine analogs of ICRF-187 (dexrazoxane).

Hasinoff BB, Kuschak TI, Yalowich JC, Creighton AM. Hasinoff BB, et al. Among authors: kuschak ti. Biochem Pharmacol. 1995 Sep 28;50(7):953-8. doi: 10.1016/0006-2952(95)00218-o. Biochem Pharmacol. 1995. PMID: 7575679

2

Metabolism of the cardioprotective agents dexrazoxane (ICRF-187) and levrazoxane (ICRF-186) by the isolated hepatocyte.

Hasinoff BB, Venkataram S, Singh M, Kuschak TI. Hasinoff BB, et al. Among authors: kuschak ti. Xenobiotica. 1994 Oct;24(10):977-87. doi: 10.3109/00498259409043295. Xenobiotica. 1994. PMID: 7900413

3

Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II.

Hasinoff BB, Kuschak TI, Creighton AM, Fattman CL, Allan WP, Thampatty P, Yalowich JC. Hasinoff BB, et al. Among authors: kuschak ti. Biochem Pharmacol. 1997 Jun 15;53(12):1843-53. doi: 10.1016/s0006-2952(97)00013-0. Biochem Pharmacol. 1997. PMID: 9256159

4

The one-ring open hydrolysis intermediates of the cardioprotective agent dexrazoxane (ICRF-187) do not inhibit the growth of Chinese hamster ovary cells or the catalytic activity of DNA topoisomerase II.

Hasinoff BB, Kuschak TI, Fattman CL, Yalowich JC. Hasinoff BB, et al. Among authors: kuschak ti. Anticancer Drugs. 1998 Jun;9(5):465-71. doi: 10.1097/00001813-199806000-00014. Anticancer Drugs. 1998. PMID: 9660545

5

A cis-trans interaction at the 3'-untranslated region of ribonucleotide reductase mRNA is regulated by TGF-beta 1, TGF-beta 2, and TGF-beta 3.

Amara FM, Smith GM, Kuschak TI, Takeuchi TL, Wright JA. Amara FM, et al. Among authors: kuschak ti. Biochem Biophys Res Commun. 1996 Nov 12;228(2):347-51. doi: 10.1006/bbrc.1996.1664. Biochem Biophys Res Commun. 1996. PMID: 8920917

6

Transforming growth factor-beta1 stimulates multiple protein interactions at a unique cis-element in the 3'-untranslated region of the hyaluronan receptor RHAMM mRNA.

Amara FM, Entwistle J, Kuschak TI, Turley EA, Wright JA. Amara FM, et al. Among authors: kuschak ti. J Biol Chem. 1996 Jun 21;271(25):15279-84. doi: 10.1074/jbc.271.25.15279. J Biol Chem. 1996. PMID: 8663000 Free article.

7

The ribonucleotide reductase R2 gene is a non-transcribed target of c-Myc-induced genomic instability.

Kuschak TI, Taylor C, McMillan-Ward E, Israels S, Henderson DW, Mushinski JF, Wright JA, Mai S. Kuschak TI, et al. Gene. 1999 Oct 1;238(2):351-65. doi: 10.1016/s0378-1119(99)00341-8. Gene. 1999. PMID: 10570963

8

c-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene.

Kuschak TI, Kuschak BC, Taylor CL, Wright JA, Wiener F, Mai S. Kuschak TI, et al. Oncogene. 2002 Jan 31;21(6):909-20. doi: 10.1038/sj.onc.1205145. Oncogene. 2002. PMID: 11840336

9

Isolation of extrachromosomal elements by histone immunoprecipitation.

Kuschak TI, Kuschak BC, Smith GM, Wright JA, Mai S. Kuschak TI, et al. Biotechniques. 2001 May;30(5):1064-8, 1070-2. doi: 10.2144/01305rr05. Biotechniques. 2001. PMID: 11355342 Free article.

10

Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression.

Mai S, Hanley-Hyde J, Rainey GJ, Kuschak TI, Paul JT, Littlewood TD, Mischak H, Stevens LM, Henderson DW, Mushinski JF. Mai S, et al. Among authors: kuschak ti. Neoplasia. 1999 Aug;1(3):241-52. doi: 10.1038/sj.neo.7900030. Neoplasia. 1999. PMID: 10935479 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters